What serious eye-related adverse reactions have been reported with bevacizumab gamma (Lytenava) injections?

Less frequently reported but more serious eye-related adverse reactions with bevacizumab gamma (Lytenava) injections were increased intraocular pressure (0.6%), transient blindness (0.3%), endophthalmitis (0.3%) and intraocular inflammation (0.3%).